Tyloxapol's branched polyoxyethylene chains give it strong surface-tension-lowering and mucus-liquefying activity, historically used in nebulized bronchopulmonary therapy (Alevaire, Tacholiquin). In research settings it is also used experimentally to block lipoprotein lipase activity, inducing acute hyperlipidemia in rodent models for lipid metabolism studies.
Tyloxapol is a non-ionic liquid polymer of the alkylaryl polyether alcohol type, formed by the oxyethylation of a formaldehyde-condensed alkylphenol. It is used as a pulmonary surfactant and mucolytic agent, and as a research tool for inducing hyperlipidemia in animal models.
| Chemical Name | Tyloxapol (Superinone; Triton WR-1339) |
| CAS Number | 25301-02-4 |
| IUPAC Name | Formaldehyde;oxirane;4-(2,4,4-trimethylpentan-2-yl)phenol (oligomeric condensate) |
| Molecular Formula | C17H28O3 (repeat unit; oligomer) |
| Molecular Weight | ~4,500-6,000 g/mol (polymeric; repeat unit MW 280. g/mol |
Historic mucolytic/surfactant agent in nebulized bronchopulmonary formulations (Alevaire, Tacholiquin) to liquefy and clear mucopurulent secretions.
Used experimentally (as Triton WR-1339) to induce acute hyperlipidemia in animal models by blocking lipoprotein lipase.
Functions as a wetting and solubilizing agent in eye drops and topical preparations.
Used to solubilize lipids and study cell membrane and macrophage endotoxin-protection mechanisms.
Biomed. Chromatogr.
Inflammation
Pharmacology
Our R&D centers specialize in the design and process development of complex heterocyclic and chiral molecules — mg to kg scale.